Gynaecologic Oncology Society of Kenya (GOSK) clinical management protocol for malignant ovarian sex cord stromal tumors in Kenya - 2026

Authors

  • Dr. Simon M. Gitau Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Margaret K. Kilonzo Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Alfred Mokomba Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Wycliffe Musalia Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Millicent S. Masinde Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Benjamin E. Odongo Department of Obstetrics and Gynecology, Kenyatta University, Nairobi, Kenya
  • Prof. Jacqueline J. Chesang' Department of Public and Global Health, University of Nairobi, Nairobi, Kenya
  • Dr. Victor T. Otieno Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Mary Njoroge Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Prof. Eunice J. Cheserem Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Bruce O. Semo Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta University, Nairobi, Kenya
  • Dr. Stella N. Njenga Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Innocent O. Maranga Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya; School of Medical Sciences, Amref International University, Nairobi, Kenya
  • Dr. Marion Diana Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Francis O. Abinya Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Gideon M. Mutua Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Naomi N. Sitati Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Isaac M. Muchiri Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Steven M. Ibua Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Anwar Z. Mohamed Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Prof. Rose J. Kosgei Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya

DOI:

https://doi.org/10.59692/1r7zmh41

Keywords:

Malignant ovarian sex cord-stromal tumors, Kenya

Abstract

Objective: To establish a standardized evidence-based approach to the management of malignant ovarian sex cord-stromal tumors (MOSCSTs) in Kenya.

Methods: This protocol was developed by adapting high-quality international clinical practice guidelines to Kenya’s healthcare system and resource context. A multidisciplinary panel comprising gynecologic oncologists, pathologists, radiologists, oncology nurses, pharmacists, radiation oncologists, public health specialists, and patient representatives led the development process. Panel members received technical training from the University of Nairobi and Kenyatta National Hospital on evidence-based guideline adaptation, including standardized appraisal, systematic evaluation of guidelines, and contextualization to local needs. A systematic literature search was conducted in PubMed and Google Scholar. Five guidelines were identified and independently appraised using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument. Four guidelines were selected for adaptation: the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology on ovarian cancer, including fallopian tube cancer and primary peritoneal cancer; the European Society for Medical Oncology (ESMO) clinical practice guidelines on non-epithelial ovarian cancer; the European Society of Gynaecological Oncology (ESGO) guidelines on non-epithelial ovarian cancers in adolescents and young adults; and the Japan Society of Gynecologic Oncology guidelines on ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. The selected guidelines were reviewed, and their recommendations were contextualized to Kenya’s healthcare infrastructure and available resources.

Results: The protocol provides recommendations on clinical evaluation, histopathological assessment, staging, laboratory investigations, imaging, and the management of MOSCSTs. It addresses surgery as the primary treatment approach, the role of adjuvant and systemic therapies, and fertility-sparing management in selected patients with early-stage disease. It also covers the multidisciplinary management of advanced, recurrent, and treatment-resistant disease, post-treatment surveillance, survivorship, and supportive and palliative care.

Recommendations: The protocol provides a standardized framework for the diagnosis, staging, treatment, and follow-up of MOSCSTs in Kenya. It emphasizes appropriate surgical management, individualized fertility-preserving approaches, multidisciplinary care, long-term surveillance, and referral for clinical trials where available, taking into account the patient’s clinical circumstances and the resources available.

References

1. National_Cancer_Taskforce_Report_July_2022.

2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209–49. doi:10.3322/caac.21660

3. Kaku T, Ogawa S, Kawano Y, Ohishi Y, Kobayashi H, Hirakawa T, et al. Histological classification of ovarian cancer. Med Electron Microsc Off J Clin Electron Microsc Soc Jpn. 2003 Mar;36(1):9–17. doi:10.1007/s007950300002 PubMed PMID: 12658347.

4. Kehoe S, Bhatla N. FIGO Cancer Report 2021. Int J Gynecol Obstet. 2021 Oct;155(S1):5–6. doi:10.1002/ijgo.13882

5. Cronin KA, Scott S, Firth AU, Sung H, Henley SJ, Sherman RL, et al. Annual report to the nation on the status of cancer, part 1: National cancer statistics. Cancer. 2022 Dec 15;128(24):4251–84. doi:10.1002/cncr.34479

6. Sköld C, Bjørge T, Ekbom A, Engeland A, Gissler M, Grotmol T, et al. Pregnancy-related risk factors for sex cord-stromal tumors and germ cell tumors in parous women: a registry-based study. Br J Cancer. 2020 Jul;123(1):161–6. doi:10.1038/s41416-020-0849-z

7. Nguyen T, Tran TM, Choo YS, Alexiadis M, Fuller PJ, Chu S, et al. Genetics and Mutational Landscape of Ovarian Sex Cord-Stromal Tumors. In: Ovarian Cancer - Updates in Tumor Biology and Therapeutics [Internet]. IntechOpen; 2021 [cited 2025 May 15]. Available from: https://www.intechopen.com/chapters/76849 doi:10.5772/intechopen.97540

8. Jiang M jiao, Le Q, Yang B wen, Yuan F, Chen H. Ovarian sex cord stromal tumors: analysis of the clinical and sonographic characteristics of different histopathologic subtypes. J Ovarian Res. 2021 Apr 17;14(1):53. doi:10.1186/s13048-021-00805-0

9. Young RH. Ovarian Sex Cord-Stromal Tumors: Reflections on a 40-Year Experience With a Fascinating Group of Tumors, Including Comments on the Seminal Observations of Robert E. Scully, MD. Arch Pathol Lab Med. 2018 Dec;142(12):1459–84. doi:10.5858/arpa.2018-0291-RA PubMed PMID: 30500284.

10. Schultz KAP, Harris AK, Schneider DT, Young RH, Brown J, Gershenson DM, et al. Ovarian Sex Cord-Stromal Tumors. J Oncol Pract. 2016 Oct;12(10):940–6. doi:10.1200/JOP.2016.016261 PubMed PMID: 27858560; PubMed Central PMCID: PMC5063189.

11.Mangili G, Sigismondi C, Frigerio L, Candiani M, Savarese A, Giorda G, et al. Recurrent granulosa cell tumors (GCTs) of the ovary: A MITO-9 retrospective study. Gynecol Oncol. 2013 Jul 1;130(1):38–42. doi:10.1016/j.ygyno.2013.04.047 PubMed PMID: 23623833.

12. Young RH. Ovarian sex cord-stromal tumors and their mimics. Pathology (Phila). 2018 Jan;50(1):5–15. doi:10.1016/j.pathol.2017.09.007 PubMed PMID: 29132723.

13. Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P, et al. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct;29:iv1–18. doi:10.1093/annonc/mdy001

14. Tokunaga H, Mikami M, Nagase S, Kobayashi Y, Tabata T, Kaneuchi M, et al. The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. J Gynecol Oncol. 2021;32(2):e49. doi:10.3802/jgo.2021.32.e49

15. Moss E, Taylor A, Andreou A, Ang C, Arora R, Attygalle A, et al. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024. Eur J Obstet Gynecol Reprod Biol. 2024 Sep;300:69–123. doi:10.1016/j.ejogrb.2024.06.025

16. Ray-Coquard I, Brown J, Harter P, Provencher DM, Fong PC, Maenpaa J, et al. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Sex Cord Stromal Tumors. Int J Gynecol Cancer. 2014 Nov;24:S42–7. doi:10.1097/IGC.0000000000000249

Published

2026-11-16

How to Cite

Gynaecologic Oncology Society of Kenya (GOSK) clinical management protocol for malignant ovarian sex cord stromal tumors in Kenya - 2026. (2026). Journal of Obstetrics and Gynaecology of Eastern and Central Africa, 38(3). https://doi.org/10.59692/1r7zmh41

Similar Articles

101-110 of 172

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 > >>